CNS Pharmaceuticals, Inc. Proceeds from Issuance of Warrants
CNS Pharmaceuticals, Inc. (CNSP) reported Proceeds from Issuance of Warrants of $4.65 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2022-03-03
- CNS Pharmaceuticals, Inc. proceeds from issuance of warrants for fiscal 2021 was $4.65M, a 67.28% decline from fiscal 2020.
- CNS Pharmaceuticals, Inc. proceeds from issuance of warrants for fiscal 2020 was $14.22M, a 38.15% increase from fiscal 2019.
- CNS Pharmaceuticals, Inc. proceeds from issuance of warrants for fiscal 2019 was $10.29M.
| Period end | Proceeds from Issuance of Warrants 12 month |
|---|---|
| 2021-12-31 | $4.65M 10-K · filed 2022-03-03 |
| 2020-12-31 | $14.22M 10-K · filed 2022-03-03 |
| 2019-12-31 | $10.29M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |